These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
516 related articles for article (PubMed ID: 26957089)
21. Number of tumor foci predicts prognosis in papillary thyroid cancer. Qu N; Zhang L; Ji QH; Zhu YX; Wang ZY; Shen Q; Wang Y; Li DS BMC Cancer; 2014 Dec; 14():914. PubMed ID: 25471041 [TBL] [Abstract][Full Text] [Related]
22. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547 [TBL] [Abstract][Full Text] [Related]
23. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma. Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492 [TBL] [Abstract][Full Text] [Related]
25. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a. Ryu YJ; Cho JS; Park MH; Yoon JH BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631 [TBL] [Abstract][Full Text] [Related]
26. Clinicopathological features of recurrent papillary thyroid cancer. Zhu J; Wang X; Zhang X; Li P; Hou H Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921 [TBL] [Abstract][Full Text] [Related]
27. Association of patient age with high-risk pathologic features in papillary thyroid cancer. Niemann AC; Reid AT; Smith J; Hammond J; DeBolle SA; Wei I; Soong-Ho Lee C; Hughes DT J Surg Res; 2017 May; 211():228-232. PubMed ID: 28501122 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma. Raffaelli M; De Crea C; Sessa L; Tempera SE; Belluzzi A; Lombardi CP; Bellantone R Endocrine; 2019 Feb; 63(2):310-315. PubMed ID: 30341706 [TBL] [Abstract][Full Text] [Related]
29. Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: Is there a need for change in the AJCC classification system? Wang LY; Nixon IJ; Palmer FL; Thomas D; Tuttle RM; Shaha AR; Patel SG; Shah JP; Ganly I Surgery; 2014 Dec; 156(6):1484-9; discussion 1489-90. PubMed ID: 25456937 [TBL] [Abstract][Full Text] [Related]
31. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study. Conzo G; Docimo G; Pasquali D; Mauriello C; Gambardella C; Esposito D; Tartaglia E; Della Pietra C; Napolitano S; Rizzuto A; Santini L BMC Surg; 2013; 13 Suppl 2(Suppl 2):S3. PubMed ID: 24267409 [TBL] [Abstract][Full Text] [Related]
32. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer. Amit M; Tam S; Boonsripitayanon M; Cabanillas ME; Busaidy NL; Grubbs EG; Lai SY; Gross ND; Sturgis EM; Zafereo ME JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):108-114. PubMed ID: 29192312 [TBL] [Abstract][Full Text] [Related]
33. Intraoperative diagnosis of central compartment lymph node metastasis predicts recurrence of patients with papillary thyroid carcinoma and clinically node-negative lateral neck and may guide extent of initial surgery. Lee CW; Gong G; Roh JL World J Surg; 2015 Jan; 39(1):194-202. PubMed ID: 25234198 [TBL] [Abstract][Full Text] [Related]
34. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma. Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062 [TBL] [Abstract][Full Text] [Related]
35. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection. Ryu YJ; Cho JS; Yoon JH; Park MH World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503 [TBL] [Abstract][Full Text] [Related]
36. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients? Ebina A; Sugitani I; Fujimoto Y; Yamada K Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223 [TBL] [Abstract][Full Text] [Related]
37. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer. Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309 [TBL] [Abstract][Full Text] [Related]
38. Clinical features and prognosis of patients with benign thyroid disease accompanied by an incidental papillary carcinoma. Wang SF; Zhao WH; Wang WB; Teng XD; Teng LS; Ma ZM Asian Pac J Cancer Prev; 2013; 14(2):707-11. PubMed ID: 23621223 [TBL] [Abstract][Full Text] [Related]
39. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma. Can N; Tastekin E; Ozyilmaz F; Sezer YA; Guldiken S; Sut N; Sarikas N; Oz Puyan F; Guler B; Ayturk S; Celik M Endocr Pathol; 2015 Sep; 26(3):218-28. PubMed ID: 26209182 [TBL] [Abstract][Full Text] [Related]
40. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]